In conclusion, this study provides a molecular basis for a novel role of genistein in simultaneously inhibiting the activation of STAT3 and other closely related oncogenic kinases, such as AKT, ERK, and p38, in prostate cancer DU145 cells (Figure 6). The gene discussed is AKT1; the disease is prostate carcinoma.